AlphaStocks
5.5
Consider Buy

BrightSpring Health Services, Inc. (BTSG)

Health Care / Health Care Services

S&P SmallCap 600

$42.01

Middle of the pack. No strong signal either way.

Consider Buy

Score based on 4 of 5 models — moderate confidence

#441out of 1127 in Health Care

Is BrightSpring Health Services, Inc. a Good Investment in 2026?

BrightSpring Health Services, Inc. (BTSG) scores 5.5 out of 10 on AlphaStocks' composite model, earning a Consider Buy rating. The Piotroski model rates BrightSpring Health Services, Inc. as Strong (7/9). However, the Greenblatt Magic Formula model rates it Caution — Top half (rank 48%). BrightSpring Health Services, Inc. currently trades above its estimated fair value of $22, suggesting limited upside at current prices. BrightSpring Health Services, Inc. ranks #441 out of 1127 stocks in the Health Care sector.

This summary is algorithmically generated and is not financial advice.

Key Metrics

P/E48.4ROE10.3Market Cap9B

Estimated Fair Value

$21.9991% above

Trading above estimated fair value. P/e of 48x implies high growth expectations.

Model-based estimate, not a price target.

5-Model Analysis

Each model evaluates this stock from a different angle. Combined, they form the composite score above.

Piotroski

Strong

7/9

Buffett

Caution

Business quality & competitive moat

Graham

Caution

Significantly above fair value

Lynch

Limited Data

Growth rate vs price (PEG)

Greenblatt

Caution

Top half (rank 48%)

Frequently Asked Questions

Is BrightSpring Health Services, Inc. (BTSG) a good investment?
Based on AlphaStocks' composite analysis, BrightSpring Health Services, Inc. (BTSG) scores 5.5 out of 10, earning a Consider Buy rating. This is a middle-of-the-pack score with no strong signal either way. Trading above estimated fair value. P/e of 48x implies high growth expectations.
What is BrightSpring Health Services, Inc.'s Piotroski F-Score?
BrightSpring Health Services, Inc.'s Piotroski F-Score status is Strong. The raw score is 7/9. The Piotroski F-Score evaluates financial health using 9 fundamental signals including profitability, leverage, and operating efficiency.
Is BTSG overvalued or undervalued?
Based on AlphaStocks' model-based fair value estimate of $22, BTSG appears overvalued. The stock currently trades 91% above its estimated fair value. Trading above estimated fair value. P/e of 48x implies high growth expectations.
How does BTSG compare to other Health Care stocks?
BrightSpring Health Services, Inc. ranks #441 out of 1127 stocks in the Health Care sector, placing it in the top 39% of its sector by composite score. This is an above-average position relative to sector peers.
What do investment models say about BTSG?
AlphaStocks evaluates BTSG using five proven investment models. Piotroski: Strong; Buffett: Caution; Graham: Caution; Greenblatt Magic Formula: Caution. These models are combined into a single composite score of 5.5/10.

Similar Stocks

PARRFTIAZN

Compare BTSG with

BTSG vs PARRBTSG vs FTIBTSG vs AZN

Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer